Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment

• Ana Cubillo Alvarez,
• Dylan Maguire and
• Ruairí P. Brannigan

Beilstein J. Nanotechnol. 2025, 16, 435–463, doi:10.3762/bjnano.16.34

Liver-targeting iron oxide nanoparticles and their complexes with plant extracts for biocompatibility

• Shushanik A. Kazaryan,
• Seda A. Oganian,
• Gayane S. Vardanyan,
• Anatolie S. Sidorenko and
• Ashkhen A. Hovhannisyan

Beilstein J. Nanotechnol. 2024, 15, 1593–1602, doi:10.3762/bjnano.15.125

• complexes on biochemical markers of liver function (ALT, AST, ALP, GGT, HDL, LDL, total cholesterol, total protein, and albumin) and morphological indicators of rat liver was investigated. Fe3O4 NPs, rutin, and T. polium extract do not show direct hepatotoxicity when administered intraperitoneally to rats

• samples on the liver of Wistar rats was identified. Keywords: biocompatibility; hepatotoxicity; iron oxide (Fe3O4) nanoparticle; rutin; Teucrium polium (T. polium); Introduction Leveraging nanotechnology, personalized medicine, and interdisciplinary collaboration is essential for overcoming the complex

• hepatotoxicity at a cumulative dose of more than 244 mg/kg over 28 days of exposure [35]. By controlling the physical properties of nanoparticles, it is possible to regulate their delivery and sequestration processes [36][37][38][39]. Depending on the size, coating, and duration of exposure, they can exhibit

Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis

• Damai Ria Setyawati,
• Fransiska Christydira Sekaringtyas,
• Riyona Desvy Pratiwi,
• A’liyatur Rosyidah,
• Rohimmahtunnissa Azhar,
• Nunik Gustini,
• Gita Syahputra,
• Idah Rosidah,
• Etik Mardliyati,
• Tarwadi and
• Sjaikhurrizal El Muttaqien

Beilstein J. Nanotechnol. 2024, 15, 1105–1116, doi:10.3762/bjnano.15.89

• characterization procedures using state-of-the-art nanomedicine manufacturing facilities allows for continuous monitoring of the production steps, which is required to maintain the consistency of nanocarriers, Despite its promises, the long-term hepatotoxicity of NPs should be carefully reviewed as 30–99% of the

Nanomedicines against Chagas disease: a critical review

• Maria Jose Morilla,
• Kajal Ghosal and
• Eder Lilia Romero

Beilstein J. Nanotechnol. 2024, 15, 333–349, doi:10.3762/bjnano.15.30

• strain; 466-fold lower dose than oral free BNZ with 1400 mg/kg TD), caused no detectable hepatotoxicity, and completely abrogated the weight loss. BNZ-PS, but not free BNZ, significantly reduced the number of parasites in the heart and the inflammation. In 2005, ultra-low doses of pH-sensitive

Prediction of cytotoxicity of heavy metals adsorbed on nano-TiO₂ with periodic table descriptors using machine learning approaches

• Joyita Roy,
• Souvik Pore and
• Kunal Roy

Beilstein J. Nanotechnol. 2023, 14, 939–950, doi:10.3762/bjnano.14.77

• metals is also time- and dose-dependent. Among many other factors, the valence state plays an important role in toxicokinetics and toxicodynamics. Many studies have shown that an increased concentration of heavy metals is correlated with the severity of hepatotoxicity and nephrotoxicity [37]. Lead causes